If nothing moves by day three, drop prices 10% and test messaging, not the product
Convergence with Combination Biology Dual and multi-agonist molecules combining GLP-1 activity with GIP and/or glucagon receptor activity are emerging and driving superior metabolic efficacy in clinical studies
Hims is a legitimate telehealth business that offers a range of healthcare services for men
Newer glucose-lowering drugs and risk of dementia: a systematic review and meta-analysis of observational studies
Meanwhile, Ntrops just cracked the code on making brain health and nutrition actually attainable
In particular, incretin-based therapies and sodium-glucose co-transporter 2 (SGLT2) inhibitors have attracted increasing interest not only for their glucose-lowering effects, but also for their broader metabolic, renal, and cardiovascular benefits